首页> 外国专利> DIPEPTIDE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FOR INCREASING LEVELS OF ENDOGENOUS GROWTH HORMONE IN A HUMAN OR OTHER ANIMALS

DIPEPTIDE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FOR INCREASING LEVELS OF ENDOGENOUS GROWTH HORMONE IN A HUMAN OR OTHER ANIMALS

机译:包含它们的双肽化合物和药物组合物,用于增加人类或其他动物的内源性生长激素水平

摘要

Compounds for increasing levels of endogenous growth hormone of the formula 998 י" ב בסיון התשס" ד - June 1, 2004 the racemic-diastereomeric mixtures and optical isomers of said compounds and the pharmaceutcally-acceptable salts and prodrugs thereof, wherein e is 0 or 1; n and w are each independently 0, 1 or 2; provided that w and n cannot both be 0 at the same time; Y is oxygen or sulfur; where the alkyl and cycloalkyl groups in the definition of R1 are optionally substituted with (C1-C4) alkyl, hydroxyl, (C1-C4) alkoxy, carboxyl, -CONH2, -S(O)m ((C1-C6) alkyl, -CO2(C1-C4) alkyl ester, 1H-tetrazol-5-yl or 1, 2 or 3 fluoro; Y1 is O, S(O)m, -C(O)NX6-, -CH=CH-, -C:C-, N(X6)C(O)-, -C(O)NX6-, -C(O)O-, -OC(O)N(X6)- or -OC(O)-; q is 0, 1, 2, 3 or 4; t is 0, 1, 2 or 3; said (CH2)q group and (CH2)t group may each be optionally substituted with hydroxyl, (C1-C4) alkoxy, carboxyl, -CONH2, -S(O)m(C1-C6) alkyl, -CO2(C1-C4) alkyl ester, 1H-tetrazol-5-yl, 1, 2 or 3 fluoro, or 1 or 2 (C1-C4) alkyl; R2 is hydrogen, (C1-C8) alkyl, -(C0-C3) alkyl-(C3-C8) cycloalkyl, -(C1-C4) alkyl-A1 or A1; where the alkyl groups and the cycloalkyl groups in the definition of R2 are optionally substituted with hydroxyl, -C(O)OX6, -C(O)N(X6)(X6), -N(X6)(X6), -S(O)m -(C1-C6) alkyl, -C(O)A1, -C(O)(X6), 999 י" ב בסיון התשס" ד - June 1, 2004 CF3, CN or 1, 2 or 3 halogen; R3 is A1, (C1-C10) alkyl, -(C1-C6) alkyl-A1, -(C1-C6) alkyl -(C3-C7) cycloalkyl, -(C1-C5) alkyl-X1-(C1-C5) alkyl, -(C1-C5) alkyl-X1-(C0-C5) alkyl-A1 or -(C1-C5) alkyl-X1- (C1-C5) alkyl-(C3-C7) cycloalkyl; where the alkyl groups in the definition of R3 are optionally substituted with -S(O)m-(C1-C6) alkyl, -C(O)OX3, 1, 2, 3, 4 or 5 halogens, or 1, 2 or 3 OX3; X1 is O, S (O)m, -N(X2)C(O)-, -C(O) N(X2)-, -OC(O)-, -C(O)O-, -CX2=CX2-, -N(X2)C(O)O-, -OC(O)N(X2)- or -C:C-; R4 is hydrogen, (C1-C6) alkyl or (C3-C7) cycloalkyl, or R4 is taken together with R3 and the carbon atom to which they are attached and form (C5-C7) cycloalkyl, (C5-C7) cycloalkenyl, a partialy saturated or fully saturated 4- to 8-membered ring having 1 to 4 heteroatoms independently selected from the group consisting of oxygen, sulfur and nitrogen, or is a bicyclic ring system consisting of a partially saturated or fully saturated 5- or 6-membered ring, fused to a partially saturated, fully unsaturated or fully saturated 5 to 6-membered ring, optionally having 1 to 4 heteroatoms independently selected from the group consisting of nitrogen, sulfur and oxygen; X4 is hydrogen or (C1-C6) alkyl or X4 is taken together with R4 and the nitrogen atom to which X4 is attached and the carbon atom to which R4 is attached and form a five to seven membered ring; R6 is a bond or is where a and b are independently 0, 1, 2 or 3; X5 and X5a are each independently selected from the group consisting of hydrogen, trifluoromethyl, A1 and optionally substituted (C1-C6) alkyl; the optionally substituted (C1-C6) alkyl in the definition of X5 and X5a is optionally substituted with a substituent selected from the group consisting of A1, OX2, -S(O)m(C1-C6) alkyl, -C(O)OX2, (C3-C7 cycloalkyl, -N(X2)(X2) and -C(O) N(X2)(X2); or the carbon bearing X5 or X5a forms one or two alkylene bridges with the nitrogen atom bearing R7 and R8 wherein each alkylene bridge contains 1 to 5 carbon atoms, provided that when one alkylene bridge is formed then X5 or X5a but not both may be on the carbon atom and R7 or R8 but not both may be on the nitrogen atom and further provided that when two alkylene bridges are formed then X5 and X5a cannot be on the carbon atom and R7 and R8 cannot be on the nitrogen atom; or X5 is taken together with X5a and the carbon atom to which they are attached and form a partially saturated or fully saturated 3- to 7-membered ring, or a partially saturated or fully saturated 4- to 8-membered ring having 1 to 4 heteroatoms independently selected from 1000 י" ב בסיון התשס" ד - June 1, 2004 the group consisting of oxygen, sulfur and nitrogen; or X5 is taken together with X5a and the carbon atom to which they are attached and form a bicyclic ring system consisting of a partially saturated of fully saturated 5- or 6-membered ring, optionally having 1 or 2 heteroatoms independently selected from the group consisting of nitrogen, sulfur and oxygen, fused to a partially saturated, fully saturated or fully unsaturated 5- or 6-membered ring, optionally having 1 to 4 heteroatoms independently selected from the group consisting of nitrogen, sulfur and oxygen; Z1 is a bond, O or N-X2, provided that when a and b are both 0 then Z1 is not N-X2 or O; R7 and R8 are independently hydrogen or optionally substituted (C1-C6) alkyl; where the optionally substituted (C1-C6) alkyl in the definition of R7 and R8 is optionally independently sub
机译:用于提高式998的内源性生长激素水平的化合物-2004年6月1日,所述化合物的外消旋-非对映异构体混合物和旋光异构体及其药学上可接受的盐和前药,其中e为0或1; n和w分别独立为0、1或2;假设w和n不能同时为0; Y是氧或硫;其中R1定义中的烷基和环烷基任选地被(C1-C4)烷基,羟基,(C1-C4)烷氧基,羧基,-CONH2,-S(O)m((C1-C6)烷基取代, -CO2(C1-C4)烷基酯,1H-四唑-5-基或1,2,3氟; Y1是O,S(O)m,-C(O)NX6-,-CH = CH-,- C:C-,N(X6)C(O)-,-C(O)NX6-,-C(O)O-,-OC(O)N(X6)-或-OC(O)-; q R 1为0、1、2、3或4; t为0、1、2或3;所述(CH 2)q基团和(CH 2)t基团可任选地被羟基,(C 1 -C 4)烷氧基,羧基, -CONH2,-S(O)m(C1-C6)烷基,-CO2(C1-C4)烷基酯,1H-四唑-5-基,1、2或3氟,或1或2(C1-C4)烷基; R 2是氢,(C 1 -C 8)烷基,-(C 0 -C 3)烷基-(C 3 -C 8)环烷基,-(C 1 -C 4)烷基-A 1或A 1;其中所述烷基和环烷基R 2的定义任选地被羟基,-C(O)OX6,-C(O)N(X6)(X6),-N(X6)(X6),-S(O)m-(C1-C6)取代烷基,-C(O)A1,-C(O)(X6),999英寸-2004年6月1日CF3,CN或1,2或3卤素; R3为A1((C1-C10 )烷基,-(C1 -C6)烷基-A1,-(C1-C6)烷基-(C3-C7)环烷基,-(C1-C5)烷基-X1-(C1-C5)烷基,-(C1-C5)烷基-X1-( C0-C5)烷基-A1或-(C1-C5)烷基-X1-(C1-C5)烷基-(C3-C7)环烷基;其中R3的定义中的烷基任选地被-S(O)m-(C1-C6)烷基,-C(O)OX3、1、2、3、4或5个卤素或1、2或3取代3 OX3; X1是O,S(O)m,-N(X2)C(O)-,-C(O)N(X2)-,-OC(O)-,-C(O)O-,-CX2 = CX2-,-N(X2)C(O)O-,-OC(O)N(X2)-或-C:C-; R 4为氢,(C 1 -C 6)烷基或(C 3 -C 7)环烷基,或R 4与R 3和它们所连接的碳原子一起形成(C 5 -C 7)环烷基,(C 5 -C 7)环烯基,具有1至4个杂原子的部分饱和或完全饱和的4至8元环,它们独立地选自氧,硫和氮,或者是由部分饱和或完全饱和的5或6-原子组成的双环系统稠合到部分饱和,完全不饱和或完全饱和的5至6元环上的一元环,该环任选地具有1-4个独立地选自氮,硫和氧的杂原子; X4是氢或(C1-C6)烷基或X4与R4和与X4相连的氮原子和与R4相连的碳原子合在一起,形成一个五至七元环; R6是一个键,或者其中a和b独立地是0、1、2或3; X5和X5a各自独立地选自氢,三氟甲基,A1和任选取代的(C1-C6)烷基; X5和X5a的定义中的任选取代的(C1-C6)烷基被选自以下的取代基任选取代:A1,OX2,-S(O)m(C1-C6)烷基,-C(O) OX2,(C3-C7环烷基,-N(X2)(X2)和-C(O)N(X2)(X2);或带有X5或X5a的碳与带有R7的氮原子形成一个或两个亚烷基桥R8,其中每个亚烷基桥含有1至5个碳原子,条件是当形成一个亚烷基桥时,X5或X5a但不都可以在碳原子上,R7或R8但不都可以在氮原子上,并且进一步提供当形成两个亚烷基桥时,X5和X5a不能在碳原子上,R7和R8不能在氮原子上;或者X5与X5a和它们所连接的碳原子结合在一起,形成部分饱和或完全饱和具有1至4个杂原子的饱和3至7元环或部分饱和或完全饱和的4至8元环1000י“בבסיוןהתשס”ד-2004年6月1日,该组由氧,硫和氮组成;或X 5与X 5a和它们所连接的碳原子一起形成一个双环系统,该环系统由部分饱和的完全饱和的5元或6元环组成,可选地具有1个或2个独立地选自下组的杂原子氮,硫和氧稠合到部分饱和,完全饱和或完全不饱和的5或6元环上,该环任选具有1-4个独立地选自氮,硫和氧的杂原子; Z1是键O或N-X2,前提是当a和b均为0时Z1不是N-X2或O; R7和R8独立地是氢或任选取代的(C1-C6)烷基;其中R7和R8的定义中的任选取代的(C1-C6)烷基任选地独立地为亚

著录项

  • 公开/公告号IL124449B

    专利类型

  • 公开/公告日2004-06-01

    原文格式PDF

  • 申请/专利权人 PFIZER INC.;

    申请/专利号IL124449

  • 发明设计人

    申请日2001-04-02

  • 分类号

  • 国家 IL

  • 入库时间 2022-08-21 23:10:42

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号